Ménière's disease: A challenging and relentless disorder

Otolaryngologic Clinics of North America

Volumn 44, Issue 2, 2011, Pages 383-403

  Semaan, Maroun T ^a   Megerian, Cliff A ^a  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

Author keywords

Cochlear hydrops; Electrocochleography; Endolymphatic hydrops; Labyrinthectomy; M ni re's disease; Vestibular evoked myogenic potentials; Vestibular nerve section

Indexed keywords

DEXAMETHASONE; DIURETIC AGENT; GENTAMICIN; HYDROCHLOROTHIAZIDE; PREDNISONE; STEROID; STREPTOMYCIN; TRIAMTERENE; VASODILATOR AGENT;

ACTION POTENTIAL; ANTIBIOTIC THERAPY; AUDIOGRAPHY; AUDITORY REHABILITATION; CLINICAL ASSESSMENT; CORTICOSTEROID THERAPY; DECOMPRESSION; DIAGNOSTIC TEST; ELECTROCOCHLEOGRAPHY; ELECTRONYSTAGMOGRAPHY; ELECTROPHYSIOLOGY; HEARING LOSS; HUMAN; IMPLANTATION; LABYRINTHECTOMY; MENIERE DISEASE; NAUSEA AND VOMITING; NYSTAGMUS; PATHOPHYSIOLOGY; PERCEPTION DEAFNESS; PRACTICE GUIDELINE; QUALITY OF LIFE; REVIEW; SODIUM RESTRICTION; TINNITUS; TREATMENT FAILURE; VERTIGO; VESTIBULAR EVOKED MYOGENIC POTENTIAL;

ADULT; AUDIOMETRY, EVOKED RESPONSE; CALORIC TESTS; DECOMPRESSION, SURGICAL; EAR, INNER; FEMALE; HEARING LOSS, SENSORINEURAL; HUMANS; MAGNETIC RESONANCE IMAGING; MENIERE DISEASE; RECURRENCE; VESTIBULAR EVOKED MYOGENIC POTENTIALS; VESTIBULAR NERVE;

EID: 79953296663     PISSN: 00306665     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.otc.2011.01.010     Document Type: Review

References (57)

1. Ménière P. Maladies de l'oreille interne offrant les symptomes de la congestion cérébrale apoplectiforme. Gaz Méd de Paris 1861, 16:88. [in French].
2. Arenberg I.K., Balkany T.J., Goldman G., et al. The incidence and prevalence of Meniere's disease-a statistical analysis of limits. Otolaryngol Clin North Am 1980, 13:597.
3. Stahle J., Stahle C., Arenberg I.K. Incidence of Meniere's disease. Arch Otolaryngol 1978, 104:99.
4. Committee on Hearing and Equilibrium guidelines for the diagnosis and evaluation of therapy in Meniere's disease. American Academy of Otolaryngology-Head and Neck Foundation, Inc. Otolaryngol Head Neck Surg 1995, 113:181.
5. Pulec J.L. Meniere's disease of syphilitic etiology. Ear Nose Throat J 1997, 76:508.
6. Hughes G.B., Barna B.P., Kinney S.E., et al. Clinical diagnosis of immune inner-ear disease. Laryngoscope 1988, 98:251.
7. Cmejrek R.C., Megerian C.A. Obstructing lesions of the endolymphatic sac and duct mimicking Meniere's disease. Ear Nose Throat J 2004, 83:753.
8. House J.W., Doherty J.K., Fisher L.M., et al. Meniere's disease: prevalence of contralateral ear involvement. Otol Neurotol 2006, 27:355.
9. Dornhoffer J.L. Diagnosis of cochlear Meniere's disease with electrocochleography. ORL J Otorhinolaryngol Relat Spec 1998, 60:301.
10. Ikeda M., Sando I. Paravestibular canaliculus in Meniere's disease. A histopathological study. Ann Otol Rhinol Laryngol Suppl 1985, 118:11.
11. Masutani H., Nakai Y., Kato A. Microvascular disorder of the stria vascularis in endolymphatic hydrops. Acta Otolaryngol Suppl 1995, 519:74.
12. Paparella M.M. The cause (multifactorial inheritance) and pathogenesis (endolymphatic malabsorption) of Meniere's disease and its symptoms (mechanical and chemical). Acta Otolaryngol 1985, 99:445.
13. Xenellis J., Morrison A.W., McClowskey D., et al. HLA antigens in the pathogenesis of Meniere's disease. J Laryngol Otol 1986, 100:21.
14. Yoo T.J., Yazawa Y., Tomoda K., et al. Type II collagen-induced autoimmune endolymphatic hydrops in guinea pig. Science 1983, 222:65.
15. Clark S.K., Rees T.S. Posttraumatic endolymphatic hydrops. Arch Otolaryngol 1977, 103:725.
16. Derebery M.J. Allergic and immunologic aspects of Meniere's disease. Otolaryngol Head Neck Surg 1996, 114:360.
17. Shea J.J., Ge X., Orchik D.J. Traumatic endolymphatic hydrops. Am J Otol 1995, 16:235.
18. Paparella M.M. Pathogenesis of Meniere's disease and Meniere's syndrome. Acta Otolaryngol Suppl 1984, 406:10.
19. Salt A.N. Regulation of endolymphatic fluid volume. Ann N Y Acad Sci 2001, 942:306.
20. Merchant S.N., Adams J.C., Nadol J.B. Pathophysiology of Meniere's syndrome: are symptoms caused by endolymphatic hydrops?. Otol Neurotol 2005, 26:74.
21. Kim H.H., Wiet R.J., Battista R.A. Trends in the diagnosis and the management of Meniere's disease: results of a survey. Otolaryngol Head Neck Surg 2005, 132:722.
22. Gatland D.J., Billings R.J., Youngs R.P., et al. Investigation of the physiological basis of summating potential changes in endolymphatic hydrops. Acta Otolaryngol 1988, 105:218.
23. Ge X., Shea J.J. Transtympanic electrocochleography: a 10-year experience. Otol Neurotol 2002, 23:799.
24. Rauch S.D., Zhou G., Kujawa S.G., et al. Vestibular evoked myogenic potentials show altered tuning in patients with Meniere's disease. Otol Neurotol 2004, 25:333.
25. Timmer F.C., Zhou G., Guinan J.J., et al. Vestibular evoked myogenic potential (VEMP) in patients with Meniere's disease with drop attacks. Laryngoscope 2006, 116:776.
26. Park H.J., Migliaccio A.A., Della Santina C.C., et al. Search-coil head-thrust and caloric tests in Meniere's disease. Acta Otolaryngol 2005, 125:852.
27. Palomar-Asenjo V., Boleas-Aguirre M.S., Sanchez-Ferrandiz N., et al. Caloric and rotatory chair test results in patients with Meniere's disease. Otol Neurotol 2006, 27:945.
28. Santos P.M., Hall R.A., Snyder J.M., et al. Diuretic and diet effect on Meniere's disease evaluated by the 1985 Committee on Hearing and Equilibrium guidelines. Otolaryngol Head Neck Surg 1993, 109:680.
29. Silverstein H., Smouha E., Jones R. Natural history vs. surgery for Meniere's disease. Otolaryngol Head Neck Surg 1989, 100:6.
30. Thirlwall A.S., Kundu S. Diuretics for Meniere's disease or syndrome. Cochrane Database Syst Rev 2006, (3). CD003599.
31. James A.L., Burton M.J. Betahistine for Meniere's disease or syndrome. Cochrane Database Syst Rev 2001, (1). CD001873.
32. Boleas-Aguirre M.S., Lin F.R., Della Santina C.C., et al. Longitudinal results with intratympanic dexamethasone in the treatment of Meniere's disease. Otol Neurotol 2008, 29:33.
33. Gottshall K.R., Hoffer M.E., Moore R.J., et al. The role of vestibular rehabilitation in the treatment of Meniere's disease. Otolaryngol Head Neck Surg 2005, 133:326.
34. Quaranta A., Marini F., Sallustio V. Long-term outcome of Meniere's disease: endolymphatic mastoid shunt versus natural history. Audiol Neurootol 1998, 3:54.
35. Telischi F.F., Luxford W.M. Long-term efficacy of endolymphatic sac surgery for vertigo in Meniere's disease. Otolaryngol Head Neck Surg 1993, 109:83.
36. Kato B.M., LaRouere M.J., Bojrab D.I., et al. Evaluating quality of life after endolymphatic sac surgery: the Meniere's Disease Outcomes Questionnaire. Otol Neurotol 2004, 25:339.
37. Brinson G.M., Chen D.A., Arriaga M.A. Endolymphatic mastoid shunt versus endolymphatic sac decompression for Meniere's disease. Otolaryngol Head Neck Surg 2007, 136:415.
38. Blakley B.W. Clinical forum: a review of intratympanic therapy. Am J Otol 1997, 18:520.
39. Nedzelski J.M., Chiong C.M., Fradet G., et al. Intratympanic gentamicin instillation as treatment of unilateral Meniere's disease: update of an ongoing study. Am J Otol 1993, 14:278.
40. Forge A., Li L. Apoptotic death of hair cells in mammalian vestibular sensory epithelia. Hear Res 2000, 139:97.
41. Nakagawa T., Yamane H., Shibata S., et al. Gentamicin ototoxicity induced apoptosis of the vestibular hair cells of guinea pigs. Eur Arch Otorhinolaryngol 1997, 254:9.
42. Chia S.H., Gamst A.C., Anderson J.P., et al. Intratympanic gentamicin therapy for Meniere's disease: a meta-analysis. Otol Neurotol 2004, 25:544.
43. Rosenberg S.I., Silverstein H., Hoffer M.E., et al. Hearing results after posterior fossa neurectomy. Otolaryngol Head Neck Surg 1996, 114:32.
44. Nguyen C.D., Brackmann D.E., Crane R.T., et al. Retrolabyrinthine vestibular nerve section: evaluation of technical modification in 143 cases. Am J Otol 1992, 13:328.
45. Green J.D., Shelton C., Brackmann D.E. Middle fossa vestibular neurectomy in retrolabyrinthine neurectomy failures. Arch Otolaryngol Head Neck Surg 1992, 118:1058.
46. Silverstein H., Jackson L.E. Vestibular nerve section. Otolaryngol Clin North Am 2002, 35:655.
47. Teufert K.B., Berliner K.I., De la Cruz A. Persistent dizziness after surgical treatment of vertigo: an exploratory study of prognostic factors. Otol Neurotol 2007, 28:1056.
48. Diaz R.C., LaRouere M.J., Bojrab D.I., et al. Quality-of-life assessment of Meniere's disease patients after surgical labyrinthectomy. Otol Neurotol 2007, 28:74.
49. Colletti V., Carner M., Colletti L. Auditory results after vestibular nerve section and intratympanic gentamicin for Meniere's disease. Otol Neurotol 2007, 28:145.
50. Kaylie D.M., Jackson C.G., Gardner E.K. Surgical management of Meniere's disease in the era of gentamicin. Otolaryngol Head Neck Surg 2005, 132:443.
51. Megerian C.A., Semaan M.T. Evaluation and management of endolymphatic sac and duct tumors. Otolaryngol Clin North Am 2007, 40:463.
52. Aftab S., Semaan M.T., Murray G.S., et al. Cochlear implantation outcomes in patients with autoimmune and immune-mediated inner ear diseases. Otol Neurotol 2010, 31(8):1337-1342.
53. Shea J.J., Ge X., Orchik D.J. Long-term results of low dose intramuscular streptomycin for Meniere's disease. Am J Otol 1994, 15:540.
54. Lustig L.R., Yeagle J., Niparko J.K., et al. Cochlear implantation in patients with bilateral Meniere's syndrome. Otol Neurotol 2003, 24:397.
55. Kartush J.M., Linstrom C.J., Graham M.D., et al. Promontory stimulation following labyrinthectomy: implications for cochlear implantation. Laryngoscope 1990, 100:5.
56. Zwolan T.A., Shepard N.T., Niparko J.K. Labyrinthectomy with cochlear implantation. Am J Otol 1993, 14:220.
57. Peterson W.M., Isaacson J.E. Current management of Meniere's disease in an only hearing ear. Otol Neurotol 2007, 28:696.